Position in LLY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$64,308,643
+$12,769,332 QoQ
Shares Held
53,616
-4.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#483
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HM PAYSON & CO holds $421,884,223 across 14 Drug Manufacturers - General names. LLY ranks #3 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
596,837 | $150,188,062 | |
| 2 | JNJ |
Johnson & Johnson
|
391,709 | $99,482,334 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
53,616 | $64,308,643 | |
| 4 | AMGN |
Amgen Inc
|
167,825 | $60,772,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
172,406 | $22,154,171 | |
| 6 | PFE |
Pfizer Inc
|
453,303 | $10,915,536 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
113,175 | $6,521,142 | |
| 8 | AZN |
Astrazeneca PLC
|
20,928 | $3,968,367 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,308,643 | 53,616 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $51,539,311 | 56,035 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $49,852,260 | 46,388 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $30,544,416 | 40,032 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $31,284,097 | 40,132 | Shares | Sole | 2025-10-17 | |
| 2025-03-31 | $17,624,919 | 21,340 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $16,634,284 | 21,547 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $19,449,039 | 21,953 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $19,533,573 | 21,575 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $18,341,962 | 23,577 | Shares | Sole | 2024-06-20 | |
| 2023-12-31 | $14,223,247 | 24,400 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $13,714,002 | 25,532 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $11,469,843 | 24,457 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $7,318,623 | 21,311 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $7,276,923 | 19,891 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $7,083,628 | 21,907 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $7,005,961 | 21,608 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,205,351 | 21,669 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,964,970 | 21,595 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $5,079,172 | 21,983 | Shares | Sole | 2021-11-30 | |
| 2021-06-30 | $4,593,154 | 20,012 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $3,705,387 | 19,834 | Shares | Sole | 2021-06-15 | |
| 2020-12-31 | $3,390,307 | 20,080 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $3,245,634 | 21,927 | Shares | Sole | 2020-12-21 | |
| 2020-06-30 | $3,636,094 | 22,147 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,095,259 | 22,313 | Shares | Sole | 2020-07-01 | |
| No filing history on record for this holder in this stock. | ||||||